11.30.17 | Policy
SWHR Urges ICER to Consider Disease Burden When Assessing Migraine Drugs
SWHR provided initial input to the Institute for Clinical and Economic Review (ICER) as it prepares to assess the effectiveness […]
11.27.17 | Policy
SWHR Concerns on Clinical Laboratory Fee Schedule
In letters to the U.S. Department of Health and Human Services and the Centers for Medicare and Medicaid Services, SWHR expressed serious […]
11.10.17 | Policy
SWHR Input on NIH Strategic Plan for Women’s Health Research
SWHR provided input on the National Institutes of Health (NIH) strategic plan for research on women’s health to stimulate new […]
5.22.17 | Policy
SWHR Supports Continuation of FDA User Fee Programs
SWHR issued a letter supporting the continuation of the Food and Drug Administration (FDA) user fee programs in order to […]
4.3.17 | Policy
SWHR Signs On to Letter on Proposed Medicare Part B Changes
SWHR signed onto a letter to the Medicare Payment Advisory Commission on reconsidering the proposed Medicare Part B changes. The coalition letter […]
1.17.17 | Policy
SWHR Calls on the New Administration to Safeguard Women’s Health
SWHR offers support to both the President Trump administration and Congress and will actively build on the progress made in advancing women’s health in the U.S. and worldwide.
7.13.16 | Policy
SWHR Comments on USPSTF Draft Recommendations for Sleep Apnea Screening
SWHR’s Sleep Network provided comments to the U.S. Preventive Services Task Force (USPSTF) on its draft recommendation on screening for […]
3.18.16 | Policy
SWHR Thanks House Appropriators for NIH Support
SWHR thanks the House Appropriators for their continued support of the National Institutes of Health.
2.24.16 | Policy
SWHR Supports Dr. Robert M. Califf’s Confirmation to Lead FDA
Dr. Robert M. Califf, distinguished cardiologist and medical researcher, has been confirmed by the U.S. Senate as the next U.S. Food and Drug Administration (FDA) Commissioner. President Barack Obama nominated Dr. Califf in September 2015.
1.13.16 | Policy
SWHR Supports HELP Committee’s Califf Approval; Urges Confirmation by Senate
The United States Senate Committee on Health, Education, Labor and Pensions (HELP) unanimously approved Dr. Robert Califf's nomination to serve as U.S. Food and Drug Administration (FDA) Commissioner, moving the process to the full Senate for a final vote.
